AI Tool Comparison
Comparing as AI Remote Patient MonitoringBiofourmis vs Current Health
Verdict by Category
Feature & Spec Matrix
Detailed Comparison21 Criteria
Complete side-by-side breakdown of specifications, capabilities, and feature parity
Swipe horizontally to compare features
Feature / Spec
Pricing Model
EnterpriseBiofourmis is an enterprise-only platform with no public pricing. All contracts are custom, negotiated directly with health systems, IDNs, hospitals, and payers.
Pricing is based on patient volume, care program type (Hospital@Home, chronic disease management, post-acute care), integration requirements, and contract term. The platform is typically deployed under value-based care arrangements where costs are linked to patient outcomes and readmission reduction.
Contact Biofourmis through biofourmis.com to request a demo and enterprise pricing discussion.
EnterpriseCustom Healthcare Enterprise Contract / Quote — Clinical demonstration upon consultation
Starting Price
Custom / Contact Sales
Custom / Contact Sales
Free Plan & Trial Scope
No free plan; enterprise contracts only — contact for demo and pricing
No free plan; enterprise contracts only — contact for demo and pricing
User Rating Score
Unrated
Unrated
Ideal Workflow / Use Case
Difference
Health systems, IDNs, and payers deploying AI-powered remote patient monitoring, Hospital@Home programs, and chronic disease management at enterprise scale
Health systems, payers, and home health agencies deploying enterprise care-at-home programs with FDA-cleared wearable RPM, telehealth, and a 24/7 clinical command center
Enterprise & Scalability
Difference
FDA 510(k) cleared platform, FDA Breakthrough Device Designation (BiovitalsHF), HIPAA compliant, Epic EHR integration, value-based care contracting, enterprise SLAs, dedicated clinical implementation support, and custom outcome-based pricing models
FDA-cleared Class II wearable device, HIPAA compliant, EHR integration, 24/7 Clinical Command Center, Zoom telehealth integration, third-party device ecosystem, enterprise SLAs, and full operational deployment support through Best Buy Health
Core Categories
Difference
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity Tools
Biovitals RPM platform — analyzes 120+ biomarkers in real time from FDA-approved wearable biosensors
Supported
Supported
Hospital@Home — delivers hospital-level care at home, reducing readmission rates and inpatient bed usage
Supported
Supported
BiovitalsHF — FDA Breakthrough Device for heart failure: optimizes medication, detects adverse reactions remotely
Difference
Biofourmis Advantage
Not listed
AI predictive analytics — machine learning models detect patient deterioration days before a critical event
Supported
Supported
Epic EHR integration — seamless data flow into existing hospital information systems
Supported
Supported
Care@Home platform — manages patients across the full continuum from acute to chronic care
Supported
Supported
Oncology remote monitoring — tracks cancer patients at home via Gaido Health integration
Supported
Supported
Personalized physiological models — individual patient baselines for highly accurate deterioration detection
Difference
Biofourmis Advantage
Not listed
Digital therapeutics pipeline — software-based therapies in development for heart failure
Difference
Biofourmis Advantage
Not listed
Value-based care alignment — platform links patient outcomes to payment models for health systems and payers
Difference
Biofourmis Advantage
Not listed
FDA-cleared wearable device — continuous ICU-level monitoring of oxygen saturation, respiration rate, pulse rate, mobility, and skin temperature
Difference
Not listed
Current Health Advantage
Third-party device integration — Bluetooth connectivity for blood glucose monitors, scales, spirometers, and other devices
Difference
Not listed
Current Health Advantage
Patient engagement tools — daily task lists, symptom surveys, secure messaging, and medication reminders via tablet
Difference
Not listed
Current Health Advantage
Backed by Best Buy Health — enterprise-scale distribution, procurement, and logistics for device deployment
Difference
Not listed
Current Health Advantage
Biofourmis Pros & Cons
Pros
- FDA 510(k) cleared + FDA Breakthrough Device Designation for BiovitalsHF — highest regulatory validation in RPM
- $461.85M raised, $1.3B unicorn valuation — General Atlantic, CVS Health, SoftBank Vision Fund 2 backing
- 120+ biomarker real-time analysis — most comprehensive predictive RPM analytics platform available
- Proven clinical outcomes — reduces hospital readmissions and enables earlier intervention days before events
- Epic EHR integration — fits natively into existing health system infrastructure without workflow disruption
- Merged with CopilotIQ (Oct 2024) — expanded to end-to-end AI in-home care across all care stages
- Hospital@Home validated program — one of few platforms with proven acute-care-at-home deployment at scale
Cons
- Enterprise-only pricing — no self-service or SMB option
- Implementation complexity — requires EHR integration and clinical workflow setup
- No public pricing — evaluation requires direct sales engagement
- Life sciences division divested to ActiGraph (Jan 2025)
- Primarily US-focused deployment despite global presence
- Not available to individual clinicians or small practices
Current Health Pros & Cons
Pros
- FDA-cleared wearable delivers ICU-level vital sign accuracy at home — highest clinical standard in consumer RPM
- Acquired by Best Buy (2021) — enterprise-scale logistics, retail distribution, and commercial backing
- Trusted by Mount Sinai, Geisinger, Mayo Clinic, UK NHS, and AstraZeneca — proven at top-tier health systems
- All-in-one platform: RPM + telehealth + patient engagement + command center in single solution
- 24/7 Clinical Command Center reduces provider burden — offloads monitoring operations from health system staff
- Customizable clinical algorithms per patient — reduces false alarms and focuses alerts on clinically meaningful signals
- Revenues grew 3,000% YoY in 2020 — proven market demand and real-world scalability
Cons
- Enterprise-only platform — not available for individual clinicians or small practices
- Requires Best Buy Health partnership for full deployment — limits flexibility for some health systems
- No public pricing — evaluation requires direct sales engagement
- Device-dependent model — requires wearable distribution logistics and patient onboarding
- Primarily focused on US and UK markets
- Competition from Biofourmis, Teladoc, and other RPM platforms with similar hospital-at-home capabilities
Head-to-Head Battle Cards
Popular Comparisons
Direct feature matrices, pricing breakdowns, and real-world benchmark duels

AI Healthcare ToolsCompare

AI Healthcare ToolsCompare

AI Healthcare ToolsCompare

AI Healthcare ToolsCompare

